Browse studies

Find your next paid study

3,226 recruiting studies matching your filters

ROSETTA Gastric-204: A Blinded, Randomized, Phase 2/3 Study of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

The purpose of this study is to evaluate the safety and efficacy of Pumitamig in combination with chemotherapy versus Nivolumab in combination with chemotherap…

Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Bristol-Myers SquibbNCT07221149

Phase 2

A Phase 2 Randomized Trial of Remodeling Intestinal Microbiota Using Fecal Microbiome Transplant (FMT) Among Recipients of Chimeric Antigen Receptor T Cells (CAR T)

This phase II trial tests how well fecal microbiome transplantation works to remodel intestinal microbiota for patients with lymphoma that has come back after …

Recurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma+3 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Phase 2

FIREFLY-1: A Phase 2, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of the Oral Pan-RAF Inhibitor DAY101 in Pediatric Patients With RAF-Altered, Recurrent or Progressive Low-Grade Glioma and Advanced Solid Tumors

This is a Phase 2, multi center, open-label study to evaluate the safety and efficacy of Type II RAF (tovorafenib) in pediatric participants with low-grade gli…

Low-grade GliomaAdvanced Solid Tumor

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Day One Biopharmaceuticals, Inc.NCT04775485

Phase 2

A Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Ri…

High-Risk Non-Muscle-Invasive Bladder Cancer

Estimated

~$75 – $2,800

Actual pay is set by the research site.

CG Oncology, Inc.NCT06567743

Observational

Hybrid Effectiveness-Implementation Trial of a School Clinician Training and Psychosocial ADHD/ODD Intervention Program Adapted for Schools Across Mexico (CLS-A-FUERTE)

Neurodevelopmental disorders of Attention-Deficit/ Hyperactivity Disorder (ADHD) and Oppositional Defiant Disorder (ODD) are extremely common but underserved w…

ADHD

Estimated

~$10 – $675

Actual pay is set by the research site.

University of California, San FranciscoNCT06457256

Phase 2

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

The purpose of this research is to determine whether bladder cancer monitoring can be improved by replacing some cystoscopy procedures with urine testing. Spec…

Non-muscle-invasive Bladder Cancer

Estimated

~$75 – $1,800

Actual pay is set by the research site.

White River Junction Veterans Affairs Medical CenterNCT05796375

Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients With Abdominal and Pelvic Tumors Undergoing Therapy

This clinical trial studies how well 3-dimensional multi-parametric ultrasound (3D MPUS) imaging works as a decision-support tool for patients with liver tumor…

Liver Cancer, Adult

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, San DiegoNCT05705219

At-home Walking Cadence Functional Assessment and Recovery Trajectory for Older Adults Undergoing Major Surgery

This is a prospective observational study looking at gait-cadence in older adults who are scheduled to have major abdominal surgery at the University of Chicag…

Gait, Unsteady

Estimated

~$10 – $750

Actual pay is set by the research site.

University of ChicagoNCT05886725

Observational

Chronic Evaluation of Novel Pacemaker System

The primary study objective is to evaluate the feasibility, initial clinical safety and potential effectiveness of the Calyan Pacemaker system.

Ventricular Pacing With Rate ResponseBradycardia

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Calyan TechnologiesNCT06056817

Phase 2

Phase2 Trial of High Dose Intravenous Ascorbic Acid as an Adjunct to Salvage Chemotherapy in Relapsed/ Refractory Lymphoma, Patients With Clonal Cytopenia of Undetermined Significance, and Chronic Myelomonocytic Leukemia

This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or does …

Clonal Cytopenia of Undetermined SignificanceHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Diffuse Large B-Cell Lymphoma+5 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Observational

Personalizing Post Surgical Thromboprophylaxis for Patients With Peripheral Artery Disease

The goal of this clinical trial is to determine whether a personalised blood clot prevention plan is more effective than standard treatment in adults with peri…

Peripheral Arterial Disease (PAD)AmputationThrombosis+4 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Massachusetts General HospitalNCT07613840

Phase 4

EVax-3: Human Upper and Lower Airway Mucosal Immune Response to FluMist Vaccination

The goal of this clinical trial is to measure the immune response in the blood, nose, and lungs after participants receive either the FDA-approved inactivated …

Healthy Young AdultsInfluenza VaccinesInfluenza Vaccine Response

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Washington University School of MedicineNCT07177417